Odyssey Health (ODYY) Net Cash Flow Growth (3y) (2017 - 2026)
Odyssey Health (ODYY) Net Cash Flow Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | -9.45% |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 60.16% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | -85.83% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 43.26% |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | -26.30% |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 21.48% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -127.77% |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 269.22% |
| 10 | Odyssey Health | 1.01 Mn | 711,880.61 | - | -109.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -109.67% |
| Jan 31, 2026 | 248.06% |
| Oct 31, 2025 | 31.91% |
| Jul 31, 2025 | -58.31% |
| Apr 30, 2025 | -26.61% |
| Jan 31, 2025 | 48.40% |
| Oct 31, 2024 | 37.55% |
| Jul 31, 2024 | 66.90% |
| Apr 30, 2024 | -27.57% |
| Jan 31, 2024 | 48.30% |
| Oct 31, 2023 | -11.18% |
| Jul 31, 2023 | -0.63% |
| Apr 30, 2023 | -51.06% |
| Jan 31, 2023 | 47.14% |
| Oct 31, 2022 | 30.19% |
| Jul 31, 2022 | 9.58% |
| Apr 30, 2022 | 666.53% |
| Jan 31, 2022 | -866.82% |
| Oct 31, 2021 | -420.40% |
| Jul 31, 2021 | -573.10% |